Faculty

Institution

Unit

Venue

Daniel M. Moreira

Associate Professor

University of Illinois Chicago

Affiliations

College of Medicine of Chicago

Urology

Daniel M. Moreira is currently serving as a College Of Medicine Of Chicago Associate Professor at University of Illinois Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel M. Moreira

University of Illinois Chicago

Associate Professor

You can click a keyword to filter the displayed items

urology prostate cancer oncology neurology surgery health sciences cancer risk cancer research radical prostatectomy cancer care clinical research search database cancer prevention prostatic disease prostate cancer risk repeat biopsy clinical trials clinical evidence tobacco control cohort studies biochemical recurrence high-grade prostate cancer nephrology metastasis genitourinary cancers survival analysis respiratory medicine cancer treatment tobacco use prostate-specific antigen medicinal research cancer management prostate inflammation surgical oncology magnetic resonance imaging cancer detection urological research renal cell carcinoma statin use disease risk assessment health disparities cancer screening castration-resistant prostate cancer cigarette smoking cancer imaging molecular diagnostics meta-analysis treatment and prevention benign prostatic hyperplasia health care disparities disease progression diabetes mellitus laparoscopy clinical evaluation lymph node dissection active surveillance clinical investigation vascular biology clinical lipidology urogynecology histopathology prognosis robot-assisted surgery cancer disparities general surgery community health prostate cancer survival systematic review clinical proteomics nuclear medicine quantitative science studies canadian studies covid-19 pandemic life prediction short-term variability health prevention outcomes research health policy patient-reported outcome risk stratification health services research patient-centered outcomes research

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic Septa Trial: Erratum. The Journal of Urology (2025)

biomarkerscancer carerisk calculatorscancer researchepidemiologypredict prostate cancerurologyprostatic diseaseclinical trialsoncologyclinical epidemiologyserum biomarkersepidemiology of cancerjama oncologyprostate cancer

Mp11-16 Beyond Obstruction: The Effect of Dutasteride on Irritative Voiding Symptoms in Men With Lower Urinary Tract Symptoms. The Journal of Urology (2025)

benign prostatic hyperplasiamedicinebladder cancerurologysexual medicinepediatric urologyvoiding dysfunctionmp11-16 beyond obstructionurological researchurogynecology

Pathogenic Variants Reveal Candidate Genes for Prostate Cancer Germline Testing for Men of African Ancestry. Nature Communications (2025)

genome biologyvariant interpretationprostate cancer germlinegeneticsurologygenitourinary cancersmolecular diagnosticsprostate cancerafrican ancestryhuman genetics

Pd04-05 a Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Diverse Cohort: Evaluation of the Stockholm3 Multi-Ethnic Septa Trial. The Journal of Urology (2025)

biomarkerscancer careepidemiologyurologyprostatic diseasebiostatisticsoncologymolecular diagnosticsprognostic biomarkersclinical epidemiologyserum biomarkersepidemiology of cancerprostate cancer

Prostate Cancer Clinicopathological Presentation in South-East Africa During the 2010 Decade. JNCI Journal of the National Cancer Institute (2025)

Sean M PatrickWinstar Mokua OmbukiJoan NdambukiMicah O OyaroMeshack BidaPamela X Y SohGail S PrinsMaria ArgosIrene BarnhoornDaniel S BrewerRaymond CampbellJenna CraddockRosalind A EelesWeerachai JaratlerdsiriMaphuti Tebogo LebeloMassimo LodaMelanie LouwPavlo LutsikIkenna C MaduekeTumisang M N MbekeDaniel M MoreiraShingai B A MutambirwaMuriuki Elias NyagaMartin ObidaMuvhulawa ObidaWillis OyiekoMulalo B RadzumaJoyce ShirindeDouglas I WalkerEdwin O O WalongDavid C WedgeAllan YienyaVanessa M HayesM S Riana BornmanPeter Mungai Ngugi

south-east africaprostatic diseaseoncologypathologyprostate cancer

Does Insulin Resistance Predict Prostate Cancer? Results From the Reduction by Dutasteride of Prostate Cancer (Reduce) Trial. Cancer (2024)

Renning ZhengJames P. DanielsDaniel M. MoreiraShakiba EslamimehrAlexis R. FreedlandLourdes Guerrios‐RiveraJay H. FowkeStephen J. Freedland

medicinepharmacologydiabetescancer managementcancer researchpredict prostate cancerurologyprostatic diseasecancer preventiononcologycancer treatmentdiabetic medicinecancer riskprostate cancerdiabetes research

Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion. Journal of Urologic Oncology (2024)

Vanessa M. HayesSean M. PatrickJoyce ShirindeWeerachai JaratlerdsiriMukudeni NenzheleleMulalo B. RadzumaKazzem GheybiWinstar MokuaMicah O. OyaroDaniel M. MoreiraIkenna C. MaduekeShingai B.A. MutambirwaGail S. PrinsMungai P. NgugiM.S. Riana Bornman

public healthhealth equityprostate cancerrural community inclusion

Pd03-05 Does Insulin Resistance Create a Bigger Prostate? Results From the Reduction by Dutasteride of Prostate Cancer Events (Reduce) Trial. The Journal of Urology (2024)

James P. DanielsJames MirochaRenning ZhengDaniel M. MoreiraStephen J. Freedland

clinical trialsprostate cancerurology

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (Septa): A Prospective Multicentered Trial. Journal of Clinical Oncology (2024)

Hari T. VigneswaranMartin EklundAndrea DiscacciatiTobias NordströmRebecca A. HubbardNathan PerlisMichael R. AbernDaniel M. MoreiraScott EggenerPaul YonoverAlexander K. ChowKara WattsMichael A. LissGregory R. ThoresonAndre L. AbreuGeoffrey A. SonnThorgerdur PalsdottirAnna PlymFredrik WiklundHenrik GrönbergAdam B. Murphy

multiethnic cohortprospective cohort studiesprostate cancer detectionclinical trialsclinical researchoncologycohort studiesprostate cancerhealth sciencescancer detection

Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-Analysis. European Urology Oncology (2023)

Brent CaoMelissa KimNatalie M. ReizineDaniel M. Moreira

multivariate network meta-analysisurologysystematic reviewcancer treatmentprostate cancer

1
2
3
4
5
24
10 / page

Daniel M. Moreira

Associate Professor

University of Illinois Chicago

Affiliations

College of Medicine of Chicago

Urology

Daniel M. Moreira is currently serving as a College Of Medicine Of Chicago Associate Professor at University of Illinois Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel M. Moreira

University of Illinois Chicago

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Mp11-16 Beyond Obstruction: The Effect of Dutasteride on Irritative Voiding Symptoms in Men With Lower Urinary Tract Symptoms. The Journal of Urology (2025)

benign prostatic hyperplasiamedicinebladder cancerurologysexual medicinepediatric urologyvoiding dysfunctionmp11-16 beyond obstructionurological researchurogynecology

Pathogenic Variants Reveal Candidate Genes for Prostate Cancer Germline Testing for Men of African Ancestry. Nature Communications (2025)

genome biologyvariant interpretationprostate cancer germlinegeneticsurologygenitourinary cancersmolecular diagnosticsprostate cancerafrican ancestryhuman genetics

biomarkerscancer careepidemiologyurologyprostatic diseasebiostatisticsoncologymolecular diagnosticsprognostic biomarkersclinical epidemiologyserum biomarkersepidemiology of cancerprostate cancer

Prostate Cancer Clinicopathological Presentation in South-East Africa During the 2010 Decade. JNCI Journal of the National Cancer Institute (2025)

south-east africaprostatic diseaseoncologypathologyprostate cancer

Does Insulin Resistance Predict Prostate Cancer? Results From the Reduction by Dutasteride of Prostate Cancer (Reduce) Trial. Cancer (2024)

Renning ZhengJames P. DanielsDaniel M. MoreiraShakiba EslamimehrAlexis R. FreedlandLourdes Guerrios‐RiveraJay H. FowkeStephen J. Freedland

public healthhealth equityprostate cancerrural community inclusion

Pd03-05 Does Insulin Resistance Create a Bigger Prostate? Results From the Reduction by Dutasteride of Prostate Cancer Events (Reduce) Trial. The Journal of Urology (2024)

James P. DanielsJames MirochaRenning ZhengDaniel M. MoreiraStephen J. Freedland

clinical trialsprostate cancerurology

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (Septa): A Prospective Multicentered Trial. Journal of Clinical Oncology (2024)

multiethnic cohortprospective cohort studiesprostate cancer detectionclinical trialsclinical researchoncologycohort studiesprostate cancerhealth sciencescancer detection

Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-Analysis. European Urology Oncology (2023)

Brent CaoMelissa KimNatalie M. ReizineDaniel M. Moreira

multivariate network meta-analysisurologysystematic reviewcancer treatmentprostate cancer

1
2
3
4
5
24
10 / page

Similar Faculty Members

William J Aronson

Institution

University of California, Los Angeles

prostatic disease

urology

James D. Brooks

Institution

Stanford University

urology

prostate cancer

Peter Gann

Institution

University of Illinois Chicago

biomarker

chemoprevention strategies

Herbert Lepor

Institution

New York University

prostatic disease

prostate cancer

Zachary Klaassen

Institution

Augusta University

prostatic disease

prostate cancer

Aasma Shaukat

Institution

New York University

preventive medicine

health policy

Susan Halabi

Institution

Duke University

oncology

urology

William J Catalona

Institution

Northwestern University

urology

prostate cancer

Ann Schwartz

Institution

Wayne State University

epidemiology

lung cancer

Xiaomei Ma

Institution

Yale University

oncology

public health

Similar Faculty Members

William J Aronson

Institution

University of California, Los Angeles

prostatic disease

urology

James D. Brooks

Institution

Stanford University

urology

prostate cancer

Peter Gann

Institution

University of Illinois Chicago

biomarker

chemoprevention strategies

Herbert Lepor

Institution

New York University

prostatic disease

prostate cancer

Zachary Klaassen

Institution

Augusta University

prostatic disease

prostate cancer

Aasma Shaukat

Institution

New York University

preventive medicine

health policy

Susan Halabi

Institution

Duke University

oncology

urology

William J Catalona

Institution

Northwestern University

urology

prostate cancer

Ann Schwartz

Institution

Wayne State University

epidemiology

lung cancer

Xiaomei Ma

Institution

Yale University

oncology

public health